Biotec Pharmacon ASA

📍 Tromsø, Norway🗓 Founded 1990👥 111 employees💰 Last funded May 2018
Biotechnology Research🌐 biotec.no
Website LinkedIn
Biotec Pharmacon is a public Norwegian group within the biotechnology sector operating through two active subsidiaries, Biotec BetaGlucans AS and ArcticZymes AS. Biotec BetaGlucans develops and manufactures immune modulating compounds for the human health sectors. The company is spearheading research on products that may prevent or treat diseases caused by failure, imbalance and over-reaction of the immune system. ArcticZymes develops and manufactures heat labile marine enzymes used in molecular biology and diagnostics aiming at OEM customers worldwide. Biotec Pharmacon group is connected to BioTech North, a biotechnology cluster based in Tromsø.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1990
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Norway
1
Frequently asked questions
Who invested in Biotec Pharmacon ASA?
Biotec Pharmacon ASA has 1 investors on record on gritt.io.
When did Biotec Pharmacon ASA last raise funding?
The most recent investment in Biotec Pharmacon ASA recorded on gritt.io was in May 2018.
When was Biotec Pharmacon ASA founded?
Biotec Pharmacon ASA was founded in 1990.
What industry is Biotec Pharmacon ASA in?
Biotec Pharmacon ASA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biotec Pharmacon ASA based?
Biotec Pharmacon ASA is headquartered in Tromsø, Norway.